A drug discovery company running an automated small-molecule synthesis lab where AI agents plan, execute, and analyze reactions on demand.
Onepot AI
Released May 19, 2026
Synthesis-aware generative model for small molecules that proposes drug-like analogs with forward routes from commercially available building blocks.